David J. Chang insider trades
Open-market stock purchases and sales by David J. Chang, Chief Medical Officer at Cabaletta Bio, Inc, from SEC Form 4 filings since Oct 24, 2019.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +44%.
Companies traded
- CABA Cabaletta Bio, Inc: 1 buy, last Mar 2, 2026